Keith DesRochers, MD
Clinical Insights
Mind
Performance
The case for nicotine (yes, really)
Nicotine has a reputation problem, and for good reason. In cigarettes, it comes with smoke, tar, combustion, and serious health risks. But separated from tobacco, the science becomes more complicated. Researchers are looking at nicotine’s measurable effects on attention, memory, and cognitive performance. This is not a casual endorsement. It is a closer look at what the science actually says, where the risks remain, and why the conversation may be more nuanced than most people think.
For most people, the word nicotine triggers immediate associations: cigarettes, addiction, cancer. It's one of the most reflexively vilified compounds in modern culture, and for good reason—tens of millions of people have lost their lives to cigarette smoking.
But as researchers take a closer look at nicotine in isolation—separate from the tobacco smoke—a more nuanced picture is emerging. One that, quite surprisingly, points to potential benefits for attention, memory, and cognitive performance.
Nicotine: guilty by association
While nicotine is the addictive substance that keeps people reaching for another pack, it isn't actually the direct cause of smoking’s deadly outcomes. In fact, the FDA considers 79 chemicals found in a cigarette to be cancer-causing substances (carcinogens), but nicotine is not one of them. That blame belongs primarily to the combustion byproducts found in tobacco smoke, such as:
• Polycyclic aromatic hydrocarbons (PAHs), 19 compounds
• Tobacco-specific nitrosamines (TSNAs), 8 compounds
• Aromatic amines, 13 compounds
• Formaldehyde and acetaldehyde
• Volatile organic compounds (VOCs), including benzene
It's this chemical cocktail, not nicotine itself, that drives the link between smoking and its most devastating outcomes, such as cancer, lung disease and cardiovascular disease. Nicotine may hook you, but the smoke does the harmful heavy lifting from there.
So if nicotine isn't the villain, what is it?
Strip away the smoke, and what you're left with is a compound with a surprisingly different profile – one that researchers are increasingly looking at not as a toxin, but as a cognitive therapeutic.
Nicotine binds to nicotinic acetylcholine receptors in the brain, and triggers the release of several key neurotransmitters. Those neurotransmitters happen to be the same chemical messengers involved in attention, learning, and memory.
In 2010, researchers at the National Institute on Drug Abuse conducted a meta-analysis reviewing 41 double-blind, placebo-controlled studies on the effects of nicotine on human performance. They found statistically significant improvements in six areas:
• fine motor skills
• alerting attention accuracy
• alerting attention reaction time
• orienting attention reaction time
• short-term episodic memory accuracy
• working memory reaction time
Perhaps most notably, both smokers and non-smokers experienced these improvements. Meaning nicotine wasn't just appearing to cause improvement by bringing smokers back to baseline. It was elevating performance in both groups.
A 2021 meta-analysis published in Acta Neurologica Scandinavica added further weight, finding that transdermal nicotine delivered via patch in non-smoking adults produced statistically significant improvements in attention specifically.
The fact that the patch, not a cigarette, was the delivery method is significant: it further isolates nicotine's effects from every other variable in the smoking equation.
What about long-term exposure and other harmful effects?
The short answer: we don't fully know yet.
Non-tobacco based nicotine delivery options include oral pouches (such as Zyn), vapes or e-cigarettes, patches, and gums. While patches and gums have been used for years to help smokers quit, vapes and oral pouches are relatively new products with little known about long term harms. Flavor additives and other potential contaminants in vapes have led to particular concerns with these products.
While the short-term evidence on attention and memory has held up across multiple independent studies, long-term exposure and effects over time are less clear.
Some studies suggest prolonged nicotine use may impair aspects of cognition or gradually alter neural signaling over time. But separating nicotine’s effects from broader smoking-related harms remains a significant challenge.
Nicotine is also known to raise heart rate and blood pressure, which can in term raise the risk of heart disease over the long term.
The bias problem
One caveat to be aware of in the landscape of nicotine research relates to longstanding attempts by the tobacco industry to discover benefits of nicotine. A 2020 systematic review from UCSF found that 59% of study authors had received prior tobacco industry funding – and more than half of those failed to disclose it.
After filtering for industry-independent researchers, the results become more mixed, particularly around memory. Attention-related findings appear to be more consistent than memory findings, even after accounting for industry ties, but the overall literature is still inconclusive.
As with any emerging area of research, the signal is worth tracking – and so is who's funding it.
Conclusion
Nicotine is more complicated than the headlines have given it credit for.
The molecule associated with addiction, cancer and death may also hold real, measurable benefits for how we focus, process, and retain information. That tension doesn't resolve neatly—and it shouldn't.
What it does do is invite a more honest conversation. Science rarely fits the story we've assigned it, and nicotine might be one of the most compelling examples of that.
—
A note from Dr. Keith
The emerging science on nicotine is genuinely interesting. This unexpected redemption story demonstrates the importance of keeping an open mind and demanding scientific rigor in our evaluation of substances we consider putting in our bodies.
At BlueWave, we steer clear of dogmatism while also maintaining a healthy degree of skepticism toward the latest trends. If there is legitimate evidence that a therapeutic may be beneficial, then we see it as our responsibility to take it seriously, no matter how odd it may seem on the surface. Similarly, we demand an equally thoughtful investigation of potential harms.
These are the conversations we love having.